GLP-1 receptor agonists and renal outcomes in patients with diabetes mellitus type 2 and diabetic kidney disease: state of the art

BACKGROUND: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are highly effective in improving glycaemic control either as monotherapy or in combination with other hypoglycaemic drugs, and have low incidence of side effects, such as hypoglycaemia, nausea and weight gain, thus increasing patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Granata, Antonio, Maccarrone, Rosario, Anzaldi, Massimiliano, Leonardi, Giuseppe, Pesce, Francesco, Amico, Francesco, Gesualdo, Loreto, Corrao, Salvatore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
CKJ Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9394722/
https://www.ncbi.nlm.nih.gov/pubmed/36003669
http://dx.doi.org/10.1093/ckj/sfac069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9394722/
https://www.ncbi.nlm.nih.gov/pubmed/36003669
http://dx.doi.org/10.1093/ckj/sfac069

Ejemplares similares